Major funding for eye research announced at the NIHR Moorfields BRC
The joint biomedical research centre (BRC) for ophthalmology, based at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, has been awarded £19 million over five years, starting on 1 April 2017.
This announcement follows an application to the Department of Health in the summer of 2016, which was assessed by an international selection panel.
Professor Sir Peng Tee Khaw, Moorfields’ Director of Research and Development and Director of the BRC, and Director of the UCL Institute of Ophthalmology, Professor Andrew Dick said:
“We are delighted to once again have been awarded a NIHR Biomedical Research Centre. This substantial investment in eye research will enable us to continue to rapidly develop and deliver life-changing treatments for our patients. With sight loss predicted to double by the year 2050, this vital funding for eye research has never been more important. This award recognises our world-leading excellence in translating basic research through to treatments and improvements for patients.”
Health Secretary, Jeremy Hunt said:
“The UK has so often led the world in health research – from the invention of the smallpox vaccine to the discovery of penicillin and the development of DNA sequencing. Today, we are making sure the UK stays ahead of the game by laying the foundations for a new age of personalised medicine. We are supporting the great minds of the NHS to push the frontiers of medical science so that patients in this country continue to benefit from the very latest treatments and the highest standards of care.”
A new £816 million investment in health research has been shared between 20 NHS and university partnerships across England through the NIHR. Each of the 20 BRCs, of which we are one, will host the development of new, ground-breaking treatments, diagnostics, prevention and care for patients in a wide range of diseases.
Adapted from Moorfields Eye Hospital press release - Click Here